Optimising Screening of Intermediate to High-risk Asymptomatic Sportsmen With Exercise Electrocardiogram (SEEPRED)

Optimising Screening of Intermediate to High-risk Asymptomatic Sportsmen With Exercise Electrocardiogram. The SEEPRED Study.

The importance of exercise electrocardiogram (ECG) is still controversial in the prevention of cardiac events among sportsmen. The aim of this study was to assess the relevance of exercise electrocardiogram (ECG) as a significant prognostic marker for cardiovascular events when any cardiovascular disease (CVD) risk factors are present.

Study Overview

Detailed Description

The SEEPRED (Sport, Exercise ECG, prediction) prospective cohort study included leisure time sportsmen over 35 years old who performed exercise electrocardiogram (ECG) screening in the Sports Medicine Unit of the University Hospital of Saint-Etienne from September 2011 to April 2016. Personal, familial history and physical examination were systematically performed before maximal exercise electrocardiogram (ECG). Cardiovascular events and changes in physical activity were searched after exercise electrocardiogram (ECG).

Study Type

Observational

Enrollment (Actual)

1500

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Saint-Étienne, France, 42055
        • CENTRE HOSPITALIER DE SAINT-ETIENNE

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Leisure tim sportmen over 35 years.

Description

Inclusion criteria:

  • Patients referred as asymptomatic by their general practitioner for an exercise electrocardiogram (ECG) screening test carried out as a standard procedure for resuming physical activity
  • Patients referred as a systematic pre-participation screening to be declared an athlete.

Exclusion criteria:

  • Patients with coronary artery disease (CAD) and
  • Patients with uninterpretable ST segment due to bundle branch block

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Sportsmen
Sportsmen (at least 1 hour of physical activity per week) over 35 years of age, referred by their doctor for a screening stress test on a bicycle ergometer in the sports medicine unit from September 2011 to August 2014

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Silent Myocardial ischemia (SMI)
Time Frame: Day 1
Determine the frequency of exercise-induced silent myocardial ischemia (SMI).
Day 1

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Gender record
Time Frame: Day 1
Gender will be recording during medical consultation in order to predict positive exercise ECG
Day 1
Age record
Time Frame: Day 1
Age will be recording during medical consultation in order to predict positive exercise ECG
Day 1
Physical activity levels record
Time Frame: Day 1
Physical activity levels will be recording during medical consultation in order to predict positive exercise ECG
Day 1
Treatment record
Time Frame: Day 1
Treatment will be recording during medical consultation in order to predict positive exercise ECG
Day 1
Cardiovascular disease (CVD) risk factors record
Time Frame: Day 1
Cardiovascular disease (CVD) risk factors will be recording during medical consultation in order to predict positive exercise ECG
Day 1
Body mass index record
Time Frame: Day 1
Body mass index will be recording during medical consultation in order to predict positive exercise ECG
Day 1
Score>5% record
Time Frame: Day 1
SCORE >5% will be recording during medical consultation in order to predict positive exercise ECG
Day 1
Maximal heart record
Time Frame: Day 1
Maximal heart rate will be recording during medical consultation in order to predict positive exercise ECG
Day 1
Maximal aerobic power record
Time Frame: Day 1
Maximal aerobic power will be recording during medical consultation in order to predict positive exercise ECG
Day 1
Maximal blood lactate level record
Time Frame: Day 1
Maximal blood lactate level will be collected in order to predict positive exercise ECG
Day 1
Suspected SMI
Time Frame: Day 1
Exercise ECG screening test
Day 1
Confirmed SMI
Time Frame: Day 1
Exercise ECG screening test
Day 1
Cardiovascular events
Time Frame: Day 1
Exercise ECG screening test
Day 1

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: DAVID HUPIN, MD, CHU ST Etienne

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2011

Primary Completion (Actual)

January 1, 2014

Study Completion (Actual)

January 1, 2019

Study Registration Dates

First Submitted

July 27, 2023

First Submitted That Met QC Criteria

August 29, 2023

First Posted (Actual)

September 6, 2023

Study Record Updates

Last Update Posted (Actual)

September 8, 2023

Last Update Submitted That Met QC Criteria

September 6, 2023

Last Verified

March 1, 2022

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • IRBN372016/CHUSTE

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Electrocardiography

Clinical Trials on Screening stress test on a bicycle ergometer (usual practise)

Subscribe